|
|
||||||||
Laboratory of Cellular Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892
| |
ABSTRACT |
|---|
|
|
|---|
We tested the hypothesis that chemical
modifications used to produce stable, oxygen-carrying, Hb-based blood
substitutes can induce cytotoxicity in endothelial cells in culture
because of altered redox activity. We examined the interaction of
hydrogen peroxide with nonmodified hemoglobin
(HbA0) and two chemically modified hemoglobins,
-cross-linked hemoglobin (
-DBBF) and its polymerized form (poly-
-DBBF). Hydrogen peroxide-induced cell death
(as assessed by lactate dehydrogenase release) in bovine aortic
endothelial cells (BAEC) was completely inhibited by all three
hemoglobin preparations, consistent with their known pseudoperoxidase activity [hemoglobin consumes peroxide as it cycles between
ferric (Fe3+) and ferryl
(Fe4+) hemes]. However,
reaction of the modified hemoglobins, but not HbA0, with hydrogen peroxide
induced apoptotic cell death (as assessed by morphological changes and
DNA fragmentation) that correlated with the formation of a long-lived
ferrylhemoglobin. A preparation of ferryl-
-DBBF free of residual
peroxide rapidly induced morphological changes and DNA fragmentation in
BAEC, indicative of apoptotic cell death. Redox cycling of chemically
modified hemoglobins by peroxide yielded a persistent ferryl iron that was cytotoxic to endothelial cells.
apoptosis; blood substitutes
| |
INTRODUCTION |
|---|
|
|
|---|
HEMOGLOBIN (Hb), when used as
an oxygen-carrying blood substitute outside the intracellular milieu of
the red cell, undergoes oxidation-reduction reactions that lead to both
the generation and the consumption of highly reactive oxygen and
nitrogen species (1). Autoxidation of oxyhemoglobin
(Fe2+) is known to lead to the
formation of the non-oxygen-carrying ferrihemoglobin (met;
Fe3+) and superoxide anion
(O
2·), which in turn dismutates
into hydrogen peroxide (37). Hb consumes nitric oxide (NO) in a series
of redox reactions to form nitrate (51) and thus effectively removes NO
as a biological transducer of vascular relaxation (1, 3, 44).
Methemoglobin and oxyhemoglobin react with hydrogen peroxide to
catalyze the removal of hydrogen peroxide, without being consumed in
the process (a property that qualifies Hb as a pseudoperoxidase
enzyme), and to generate ferrylhemoglobins (Fe4+) as a transient
intermediate (23). Ferrylhemoglobin is a strong oxidizing agent that is
believed to mediate the peroxidation of lipids, proteins,
carbohydrates, and nucleic acids (20, 25).
Early clinical use of cell-free Hb as a blood substitute was limited by the significant in vivo toxicities observed in clinical trials (5, 50) and in animal studies (21, 35). These toxicities present as dysregulation of hemostasis and include hypertension, bradycardia (5, 50), decreased glomerular filtration rate and renal plasma flow (10), mild prolongation of partial thromboplastin time (50), disseminated intravascular coagulation with resultant thrombosis (21, 35), and ischemic parenchymal damage (21, 35). Clinical experience with the current generations of highly purified Hb-based products has identified new toxicity and efficacy problems. These include vasoconstriction, a short intravascular half-life, rapid autoxidation (34), and potential free radical-mediated toxicity (1).
The endothelial cells lining the vasculature are particularly sensitive targets for oxidation products generated by cell-free Hb, because of direct and continuous contact of the endothelium with circulating blood. Endothelial cell damage will disrupt normal vascular control of coagulation, vessel tone and tension, and vessel permeability (17, 41). Several in vitro studies on Hb interactions with cells in culture show that Hb either can be directly cytotoxic or can alter the endothelial cell state in a number of ways. Concentrations of Hb that are not directly cytotoxic (<100 µM) damage endothelial cells by disrupting cytoskeletal structures (16), by sensitizing endothelial cells in culture to hydrogen peroxide (6) and other cytotoxic agents (43), and by inducing genes that protect against oxidative damage, such as heme oxygenase (8, 38, 39) and transferrin (7, 8). Concentrations of Hb >100 µM are directly cytotoxic to endothelium (39, 52), with an apparent correlation between cytotoxicity and the extent of Hb oxidation. Native human Hb oxidized to its ferric form is more cytotoxic toward vascular endothelium than oxyhemoglobin (39). The cytotoxicity of oxyhemoglobin is dependent on the rate of Hb autoxidation and correlates with the time in culture and the presence of the iron chelator deferoxamine but not catalase, a powerful scavenger of hydrogen peroxide (39). Oxidation of Hb generates a number of products that could mediate cellular cytotoxicity including oxygen free radicals, hydrogen peroxide (43), higher oxidation states of Hb such as the ferryl heme (Fe4+) (16, 39), and free heme released after protein damage (6).
In this study, the effects of native Hb on hydrogen peroxide cytotoxicity toward bovine aortic endothelial cells (BAEC) in culture were compared with the effects of two chemically modified Hb, developed as blood substitutes, that differ from native Hb in their susceptibility to oxidation by hydrogen peroxide (12, 39). We document that ferrylhemoglobin, formed by the reaction of hydrogen peroxide with the chemically modified Hb, is a mediator of cytotoxicity. This may provide a plausible mechanism for some of the in vivo toxicities seen with infusion of these products (30). These findings may also be relevant to current efforts directed toward the design of a new generation of Hb-based blood substitutes with a reduced propensity to enter into oxidative reactions and thus protect against heme-mediated toxicity (49).
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Materials. Acridine orange, ethidium bromide, and the lactate dehydrogenase (LDH) assay kit were from Sigma Chemical (St. Louis, MO). [methyl-3H]Thymidine (4 Ci/mmol) was from ICN Biomedicals (Costa Mesa, CA). Dulbecco's modified Eagle's medium (low glucose), fetal bovine serum, heparin, and L-glutamine were from Life Technologies (Grand Island, NY).
Nonmodified Hb (HbA0) is a chromatographically purified human Hb prepared as previously described (14).
-DBBF is a human-derived, stroma-free Hb stabilized by
cross-linking of the
-subunits with bis(3,5-dibromosalicyl)fumarate
as previously described (53); it is a tetramer consisting of 2
- and
2
-subunits with a molecular mass of 64 kDa.
HbA0 and
-DBBF were kind gifts
from the Walter Reed Army Institute of Research, Washington, DC.
Polymerized
-DBBF (poly-
-DBBF), a kind gift from Baxter
Corporation, was prepared by reacting bis(maleoglycylamide)
polyethylene (BMAA-PEG) with
-DBBF to produce a protein with an
average molecular mass of 400 kDa (range 320-640 kDa)
(28). The oxygen transport characteristics of
-DBBF
[oxygen half-saturation pressure
(P50) of 28 mmHg] and its
polymerized form (P50 of 20 mmHg)
are close to that of human blood. Additional functional
and oxidation reaction properties of these proteins were previously
published (2). Optical spectra of each Hb solution were recorded on a
Hitachi U-2000 spectrophotometer (Hitachi Instruments) in both the
visible and Soret regions (47). Multicomponent analysis was used to
calculate the oxy, met, and ferryl forms of Hb based on the extinction
coefficients of each species (56).
Isolation of BAEC. Endothelial cells were isolated from the vessel wall of bovine aorta (Mt. Airy Meat Locker, Mt. Airy, MD) as previously described (15). The purified endothelial cell population exhibited the characteristic cobblestone, nonoverlapping morphology of confluent monolayers and the presence of uniformly distributed acetylated low-density lipoprotein uptake, identified with the fluorescent probe 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (Biomedical Technologies, Stoughton, MA) (55). BAEC were maintained in culture with Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum, 0.05 mg/ml heparin, 0.025 mg/ml ascorbate and 2 mM L-glutamine in a 5% CO2 incubator at 37°C (BAEC-DMEM). Experimental data were obtained from BAEC in the 2nd to 10th passages.
Measurement of DNA fragmentation and LDH release.
DNA fragmentation was quantitated using a filtration assay to separate
intact chromatin from DNA fragments (13, 36). Briefly, 2 × 104 BAEC were plated per well of a
96-well tissue culture plate with BAEC-DMEM containing 0.2 µCi
[3H]thymidine. After
BAEC were cultured for 2 days, the medium containing [3H]thymidine was
removed and replaced with fresh medium. The BAEC were placed back in
culture overnight to wash out residual free [3H]thymidine before
being cultured with the indicated treatments for 6 or 24 h. Each
treatment condition was performed in replicates of five. In experiments
to determine the effect of Hb on hydrogen peroxide cytotoxicity, Hb was
added to BAEC immediately before the addition of hydrogen peroxide. At
the end of the incubation the plates were stored at
70°C for
at least 24 h. After the plates were thawed, BAEC and the medium were
aspirated onto glass fiber filters with a microcell harvester (Skatron
Instruments, Sterling, VA). The radioactivity on the filters was
quantitated with the LKB Betaplate Beta counter (Wallac, Gaithersburg,
MD). A control sample of BAEC incubated in BAEC-DMEM was used to
determine 100% intact chromatin. Percent DNA fragmentation was
calculated as the average difference in intact DNA between the test and
control samples divided by the control (13, 36).
Preparation of ferrylhemoglobin.
A stock solution of 30% (wt/vol) hydrogen peroxide was added to 4 mM
-DBBF prewarmed to 37°C to yield a final concentration of 40 mM
hydrogen peroxide. The solution was incubated at 37°C for 1 min and
then loaded onto a 5-ml Sephadex G-25 column preequilibrated with 50 mM
sodium phosphate, pH 7.2 at 4°C. The heme-containing fraction
eluting from the column in the void volume was collected, analyzed
spectrally, and stored on ice until use. Samples of the reaction
mixture were monitored spectrally over the range from 380 to 700 nm
using a Hewlett-Packard 8452A diode-array spectrophotometer. The
proportion of oxyhemoglobin and its oxidation products, including the
ferrylhemoglobin, were determined according to earlier published work
(2). Spectral analysis of the column-purified material revealed that
45-50% of the heme was in the ferryl state and free of residual
hydrogen peroxide.
Assessment of changes in cellular morphology. BAEC were cultured in six-well tissue culture dishes without and with the indicated additives. An equal volume of PBS containing 0.01 mg/ml ethidium bromide and 0.003 mg/ml acridine orange was added to the BAEC culture at the end of 6 h and incubated in the dark at room temperature for 5 min (4, 18). Fluorescence staining of BAEC was visualized with an inverted microscope (Diaphot 300, Nikon, Melville, NY) using a fluorescein filter set.
Statistical analysis. Data are expressed as means ± SE for replicate experiments. The differences between treatment groups were assessed by one-way ANOVA followed by Student's unpaired t-test. Statistical significance was defined as P < 0.05 to reject a null hypothesis. All statistical calculations were performed with JMP version 3.2 for the Macintosh (SAS Institute, Cary, NC).
| |
RESULTS |
|---|
|
|
|---|
Peroxide-induced killing of BAEC. Hydrogen peroxide exhibited a steep dose-response curve for inducing cell death in BAEC (Fig. 1), in keeping with the well-established deleterious effects of peroxide on tissues and organs (29). Analysis of variance of the DNA fragmentation and LDH release data showed that the increasing cytotoxicity observed with increasing hydrogen peroxide was statistically significant (P < 0.001 and P = 0.0017, respectively). Both DNA fragmentation and LDH release were observed within 6 h after the addition of 1 mM hydrogen peroxide to the cell culture system, indicating that both apoptotic and necrotic cell death had occurred. This mixture of cell death pathways was confirmed by observed changes in cellular morphology (Fig. 2B). The condensed and fragmented nuclei stained with acridine orange alone (green color, indicated in Fig. 2B by arrows) are characteristic of apoptotic cell death. The enlarged nuclei stained with ethidium bromide (red or orange color in Fig. 2) are characteristic of necrotic cell death (4).
|
|
Direct effects of Hb on BAEC.
Incubation of BAEC with any of the three Hb preparations (over
concentration range 20-200 µM) for 6 h consistently produced a
<20% increase in DNA fragmentation and LDH, values that are below
the sensitivity of these assays to detect significant cytotoxicity under our conditions. Consequently, we observed no significant increase
in cytotoxicity compared with control BAEC incubated in the absence of
added Hb. The morphology changes induced by
-DBBF in BAEC were
characteristic of all three cell-free Hb preparations and indicated
that <15% of the BAEC had undergone apoptotic cell death (Fig.
2C). Those BAEC that had undergone
apoptotic cell death had rounded up or detached from the culture dish
and exhibited condensed or fragmented nuclei stained with acridine
orange. These BAEC also excluded ethidium bromide, which represents an
earlier stage of apoptosis in which the plasma membrane is still
intact. The morphology changes induced by
HbA0 and poly-
-DBBF were
identical to that seen with
-DBBF (data not shown).
Cytotoxicity of Hb and peroxide mixtures.
The cytotoxic effects of Hb and hydrogen peroxide mixtures at several
different concentrations of hydrogen peroxide, ranging from 1:1 to 1:20
molar ratios of heme to peroxide, were examined (Fig.
3). Mixtures of hydrogen peroxide and
HbA0 containing subcytotoxic concentrations of hydrogen peroxide (
0.2 mM) were not cytotoxic. At
higher concentrations of hydrogen peroxide, which gave nearly complete
cytotoxicity at 24 h, the addition of
HbA0 completely inhibited
cytotoxicity.
-DBBF and poly-
-DBBF appeared to have a small
inhibitory effect on the DNA fragmentation and LDH release induced by 1 mM hydrogen peroxide, but this apparent decrease was not statistically
significant. Like HbA0,
-DBBF
and poly-
-DBBF did not enhance cytotoxicity at subcytotoxic levels
of hydrogen peroxide.
|
-DBBF mixture, only apoptotic nuclei
were observed. None of the cells showed signs of necrotic cell death
(enlarged nuclei and ethidium bromide staining).
Further analysis of the cytotoxicity of
-DBBF and hydrogen peroxide
mixtures revealed that cytotoxicity was also a function of
-DBBF
concentration (Fig. 4). At a fixed
concentration of 1 mM hydrogen peroxide, concentrations of
-DBBF as
low as 50 µM almost completely inhibited cytotoxicity. As the
-DBBF concentration increased, however, cytotoxicity increased in
parallel with the inherent cytotoxicity of the
-DBBF alone. Hydrogen
peroxide significantly (P = 0.0022, multiple analyses of variance) increased the apparent cytotoxicity of
the mixture compared with
-DBBF alone (Fig. 4). Comparable data were
obtained with poly-
-DBBF (data not shown).
|
-DBBF mixture. To examine this possibility further,
-DBBF was reacted with hydrogen peroxide for varying lengths of time
and the concentration of ferrylhemoglobin was measured (Figs.
5A and 6).
The spectra in Fig. 5A show that a
maximal level of ferrylhemoglobin was formed during the first minute of
the reaction of
-DBBF with hydrogen peroxide, followed by a
time-dependent decrease in the steady-state level of ferrylhemoglobin with a corresponding increase in the methemoglobin level as hydrogen peroxide was consumed. To assess whether ferrylhemoglobin might contribute to cytotoxicity,
-DBBF and hydrogen peroxide were incubated for increasing amounts of time before an aliquot of the
reaction mixture was added to BAEC. LDH release and DNA fragmentation were then assessed after 24 h (Fig. 6).
There was a correlation (P < 0.05) between the concentration of
-DBBF in the ferryl form present at the time the reaction mixture was added to the cells and the
amount of cytotoxicity observed as measured by either LDH release (Fig.
6, inset) or DNA
fragmentation. This correlation supports a role for
ferrylhemoglobin as a mediator of the cytotoxicity in this situation
but does not rule out the possibility that residual hydrogen peroxide
present in the reaction mixture might also contribute.
|
|
Direct cytotoxicity of ferryl-
-DBBF.
To rule out the possibility that residual hydrogen peroxide in the
reaction mixture with
-DBBF was responsible for the cytotoxicity, we
prepared ferrylhemoglobin in which the hydrogen peroxide was removed by
column chromatography. Spectral analysis of the Hb after removal of
hydrogen peroxide showed that the preparation contained between 45 and
50% ferryl-
-DBBF (Fig. 5B). The
removal of hydrogen peroxide enhanced the stability of the ferryl form. At the end of a 60-min incubation with hydrogen peroxide continuously present, ferryl-
-DBBF completely converted back to methemoglobin (Fig. 5A). In contrast, reaction of
-DBBF with hydrogen peroxide followed by chromatographic removal of
the hydrogen peroxide yielded a preparation of ferryl-
-DBBF in which
<5% of ferryl-
-DBBF converted to methemoglobin after 60 min. This
ferryl-
-DBBF preparation showed a high degree of cytotoxicity toward
BAEC as assessed by DNA fragmentation (Fig.
7). This preparation was consistently two-
to threefold more cytotoxic than oxy-
-DBBF alone.
Ferryl-
-DBBF-induced cytotoxicity was caused entirely by apoptosis,
because LDH release was not significantly increased above control
levels (18.2 ± 1.6 vs. 14.5 ± 1.3%, without and with 100 µM
ferryl-
-DBBF, respectively; n = 3).
Morphological examination of the BAEC revealed that the ferryl-
-DBBF
had induced apoptotic cell death in the BAEC (Fig. 8), consistent with apoptotic cell death
induced by the
-DBBF and hydrogen peroxide mixture (Fig.
2D). This further supports a role
for ferrylhemoglobin as a mediator of cytotoxicity under these
conditions.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The endothelial cells lining the vasculature are particularly sensitive to oxidative stress (41). When endothelial cells are damaged, normal vasculature control of coagulation, vessel tone, and vessel permeability are disrupted (17). Several in vitro studies have demonstrated that coculture of Hb with endothelial cells generates an oxidative stress. Incubation of endothelial cells with Hb concentrations <100 µM induces the biosynthesis of protective enzymes (7, 42), whereas Hb concentrations >100 µM induce cell death (39, 52). These studies have identified several potential candidates for the agent(s) that is responsible for the Hb-induced endothelial cell cytotoxicity but have not directly established the critical factors.
Cellular toxicity induced by cell-free Hb appears to be a consequence of its oxidation state. In the absence of added oxidants, HbA0 induced <20% increase in endothelial cell cytotoxicity, in agreement with results obtained in other laboratories using stroma-free Hb (6, 52). However, Motterlini et al. (39), using HbA0, reported much higher levels of cytotoxicity in porcine aortic endothelial cells in the absence of serum. Methemoglobin (Fe3+), formed by the oxidation of HbA0, induces greater cytotoxicity than oxyhemoglobin (Fe2+) (52). Inhibitors of iron oxidation such as deferoxamine (16, 40) and scavengers of reactive oxygen species such as superoxide dismutase and catalase (43) protect against Hb-induced cytotoxicity and thus support a role for oxidation-reduction reactions. The release of free heme or iron after oxidation of Hb and the subsequent uptake of the iron by endothelial cells may also be a necessary part of the cytotoxicity process. Uptake of free heme is cytotoxic to endothelial cells in that preincubation with Hb or free heme sensitizes endothelial cells to hydrogen peroxide-induced cytotoxicity (7, 9). Intracellular heme iron could then catalyze the formation of several cytotoxic and highly reactive oxygen and nitrogen species from superoxide, hydrogen peroxide, and nitric oxide endogenously produced by endothelial cells (17, 33).
At the lower heme concentrations used in our experiments (20 µM), all three cell-free Hb preparations attenuated hydrogen peroxide-induced cytotoxicity, even concentrations of hydrogen peroxide higher than those likely to be produced during inflammatory reactions (26). This effect is likely caused by the pseudoperoxidase activity of these proteins (31). Hb consumes hydrogen peroxide in a series of reactions that involve cycling of Hb between the methemoglobin form (Fe3+) and the ferrylhemoglobin form (Fe4+) (23). The pseudoperoxidase activity of hemoproteins that involves the intermediacy of ferryl heme is well recognized and has been shown to be a real phenomenon in biological systems (19, 45). Modified Hb exhibit a slower reaction rate for conversion of ferrylhemoglobin back to methemoglobin, but they still have a sufficiently active peroxidase activity (20) to protect the endothelial cells against cytotoxicity from hydrogen peroxide.
We showed previously (2, 48) that oxidation of both
-DBBF and
poly-
-DBBF by hydrogen peroxide gives rise to a more stable ferryl
intermediate that persists for long periods of time and that could
potentially contribute to the cytotoxicity of the Hb. Comparison of
HbA0 with chemically modified Hb
revealed that at higher concentrations of these modified Hb the
production and persistence of ferrylhemoglobin in solutions
generated a distinct mode of cytotoxicity that offset its protective
effects. The importance of ferrylhemoglobin as a mediator of
cytotoxicity was supported by the correlation between cytotoxicity and
the concentration of ferrylhemoglobin present at the start of the
incubation and the cytotoxicity induced by ferrylhemoglobin after
chromatographic removal of hydrogen peroxide.
The transient nature of ferrylhemoglobin has made it difficult to
definitively show that ferrylhemoglobin mediates cytotoxicity. Ferrylheme iron and ferrylhemoglobin have been shown to catalyze the
peroxidation of lipids in cell-free systems (22, 27, 48). In one study,
-DBBF was more effective than
HbA0 in the peroxidation of lipid
vesicles (48). Studies on hydrogen peroxide cytotoxicity toward
endothelial cells have proposed that the formation of ferryl iron
within the cell, even in the absence of exogenously added Hb, was
responsible for mediating hydrogen peroxide cytotoxicity (33). The
stability of the ferryl iron in
-DBBF has provided an excellent tool
for demonstrating the direct cytotoxic effects of ferrylhemoglobin and
has demonstrated a good correlation with the levels of ferrylhemoglobin
and the extent of cell death induced by these preparations.
The reaction of Hb/myoglobin with hydrogen peroxide involves a two-electron oxidation process. One oxidation equivalent has been shown to reside on the globin as a transient radical located on an aromatic amino acid residue, whereas the second, longer lived oxidizing radical is believed to be the oxyferryl complex (Fe4+==O) (22, 23, 25). The globin-based radical and ferrylhemoglobin were recently detected by electron paramagnetic resonance in normal human blood (54). In this study the authors suggest that the source of peroxide in blood required for the reaction was the dismutation of superoxide produced via the autoxidation of intraerythrocytic Hb. It is interesting to note that this reaction occurred despite the presence of normal blood-reducing mechanisms (54). Under conditions of ischemia and reperfusion, patients have a diminished ability to control the oxidative reactions of Hb, thus raising the concern that the use of cell-free Hb as a blood substitute may in fact lead to an in vivo production and persistence of ferrylhemoglobin in tissue. Ferrylheme is able to oxidize critical targets such as unsaturated fatty acids or membrane lipoproteins and to contribute to postischemic reperfusion tissue injury (47). This hypervalent heme species has, therefore, all the attributes necessary to be considered a potential mediator of free radical damage to endothelial cells. Our data provide the first evidence that a peroxide-mediated oxidation of chemically modified Hb produces a persistent ferrylheme that is capable of inducing toxicity in endothelial cells in culture and that, unlike the case of native Hb, intermolecular and intramolecular cross-linking may have locked the proteins into a conformation that is more susceptible to the formation of a stable ferryl radical (12, 47). This work may also have some relevance to current research efforts by many in the field to suppress or control Hb oxidation reactions. Site-directed mutagenesis has recently been used to suppress the autoxidation reactions of myoglobin, a blood substitute prototype, and its reactions with nitric oxide, an important biological transduction molecule (18a). Other, more direct chemical strategies are aimed at cycling ferrylheme back to ferric heme, either by simulating a catalase-like activity in hemoproteins using an active redox compound such as nitroxides (32) or by addition of Trolox, an analog of vitamin E (24, 45).
| |
ACKNOWLEDGEMENTS |
|---|
The opinions and assertions contained herein are the scientific views of the authors and are not to be construed as policy of the United States Food and Drug Administration.
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: A. I. Alayash, Bldg. 29, Rm. 112, Center for Biologics Evaluation and Research, FDA, 8800 Rockville Pike, Bethesda, MD 20892
Received 11 February 1998; accepted in final form 14 April 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Alayash, A. I.,
and
R. E. Cashon.
Hemoglobin and free radicals: implications for the development of a safe blood substitute.
Mol. Med. Today
1:
122-127,
1995[Medline].
2.
Alayash, A. I.,
J. C. Fratantoni,
C. Bonaventura,
J. Bonaventura,
and
E. Bucci.
Consequences of chemical modifications on the free radical reactions of human hemoglobin.
Arch. Biochem. Biophys.
298:
114-120,
1992[Medline].
3.
Alayash, A. I.,
J. C. Fratantoni,
C. Bonaventura,
J. Bonaventura,
and
R. E. Cashon.
Nitric oxide binding to human ferrihemoglobins cross-linked between either
or
subunits.
Arch. Biochem. Biophys.
303:
332-338,
1993[Medline].
4.
Al-Rubeai, M.
Apoptosis and cell culture technology.
In: Advances in Biochemical Engineering/Biotechnology, edited by I. Scheper. Berlin: Springer, 1997, p. 225-249.
5.
Amberson, W. R.,
J. J. Jennings,
and
C. M. Rhode.
Clinical experience with hemoglobin-saline solutions.
J. Appl. Physiol.
1:
469-489,
1949
6.
Balla, J.,
H. S. Jacob,
G. Balla,
K. Nath,
J. W. Eaton,
and
G. M. Vercellotti.
Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage.
Proc. Natl. Acad. Sci. USA
90:
9258-9289,
1993.
7.
Balla, G.,
H. S. Jacob,
J. Balla,
M. Rosenberg,
K. Nath,
F. Apple,
J. W. Eaton,
and
G. M. Vercellotti.
Ferritin: a cytoprotective antioxidant strategem of endothelium.
J. Biol. Chem.
267:
18148-18153,
1992
8.
Balla, J.,
K. A. Nath,
G. Balla,
M. B. Juckett,
H. S. Jacob,
and
G. M. Vercellotti.
Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo.
Am. J. Physiology
268 (Lung Cell. Mol. Physiol. 12):
L321-L327,
1995
9.
Balla, G.,
G. M. Vercellotti,
U. Muller-Eberhard,
J. Eaton,
and
H. S. Jacob.
Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species.
Lab. Invest.
64:
648-655,
1991[Medline].
10.
Brandt, J. L.,
N. R. Frank,
and
H. C. Lichtman.
The effects of hemoglobin solutions on renal functions in man.
Blood
6:
1152-1158,
1951
11.
Cabaud, P. G.,
and
F. Wroblewski.
Colorimetric measurement of lactic dehydrogenase activity of body fluids.
Am. J. Clin. Pathol.
30:
234-236,
1958.
12.
Cashon, R. E.,
and
A. I. Alayash.
Reactions of human hemoglobin Ao and two cross-linked derivatives with hydrogen peroxide: differential behavior of the ferryl intermediate.
Arch. Biochem. Biophys.
316:
461-469,
1995[Medline].
13.
Chow, S. C.,
D. J. McConkey,
S. Orrenius,
and
M. Jondal.
Quantitation of DNA fragmentation using fiberglass filters.
Anal. Biochem.
183:
42-45,
1989[Medline].
14.
Christensen, S. M.,
F. Medina,
R. M. Winslow,
S. M. Snell,
A. Zegna,
and
M. A. Marini.
Preparation of human hemoglobin Ao for possible use as a blood substitute.
J. Biochem. Biophys. Methods
17:
143-154,
1988[Medline].
15.
Colden-Stanfield, M.,
E. B. Cramer,
and
E. K. Gallin.
Comparison of apical and basal surfaces of confluent endothelial cells: patch-clamp and viral studies.
Am. J. Physiol.
263 (Cell Physiol. 32):
C573-C583,
1992
16.
Comair, Y. G.,
H. M. Schipper,
and
S. Brem.
The prevention of oxyhemoglobin-induced endothelial and smooth muscle cytoskeletal injury by deferoxamine.
Neurosurgery
32:
58-65,
1993[Medline].
17.
Darley-Usmar, V.,
and
R. White.
Disruption of vascular signalling by the reaction of nitric oxide with superoxide: implications for cardiovascular disease.
Exp. Physiol.
82:
305-316,
1997[Abstract].
18.
Echaniz, P.,
M. D. Dejuan,
and
E. Cuadrado.
DNA staining changes associated with apoptosis and necrosis in blood lymphocytes of individuals with HIV infection.
Cytometry
19:
164-170,
1995[Medline].
18a.
Eich, R. F.,
T. Li,
D. D. Lemon,
D. H. Doherty,
S. R. Curry,
J. F. Aitken,
A. J. Mathews,
K. A. Johnson,
R. D. Smith,
G. N. Phillips, Jr.,
and
J. S. Olson.
Mechanism of NO-induced oxidation of myoglobin and hemoglobin.
Biochemistry
35:
6976-6983,
1996[Medline].
19.
Everse, J.,
and
N. Hsia.
The toxicities of native and modified hemoglobins.
Free Radic. Biol. Med.
22:
1075-1099,
1997[Medline].
20.
Everse, J.,
M. C. Johnson,
and
M. A. Marini.
Peroxidative activities of hemoglobin and hemoglobin derivatives.
In: Methods of Enzymology San Diego, edited by J. Everse,
K. D. Vandegriff,
and R. M. Winslow. New York: Academic, 1994, vol. 231, p. 547-561.
21.
Feola, M.,
J. Simoni,
P. C. Canizaro,
R. Tran,
and
G. Raschbaum.
Toxicity of polymerized hemoglobin solutions.
Surg. Gynecol. Obstet.
166:
211-222,
1988[Medline].
22.
Galaris, D.,
A. Sevanian,
E. Cadenas,
and
P. Hochstein.
Ferrylmyoglobin-catalyzed linoleic acid peroxidation.
Arch. Biochem. Biophys.
281:
163-169,
1990[Medline].
23.
Giulivi, C.,
and
K. J. A. Davies.
A novel antioxidant role for hemoglobin. The comproportionation of ferrylhemoglobin with oxyhemoglobin.
J. Biol. Chem.
265:
19453-19460,
1990
24.
Giulivi, C.,
F. J. Romero,
and
E. Cadenas.
The interaction of Trolox C, a water-soluble vitamin E analog, with ferrylmyoglobin: reduction of the oxyferryl moiety.
Arch. Biochem. Biophys.
299:
302-312,
1992[Medline].
25.
Grisham, M. B.,
and
J. Everse.
Pro-oxidant activity of hemoglobin and myoglobin.
In: Peroxidases in Chemistry and Biology, edited by J. Everse,
K. E. Everse,
and M. B. Grisham. Boca Raton, FL: CRC, 1991, p. 335-344.
26.
Grisham, M. B.,
T. S. Gaginell,
C. Von Ritter,
H. Tamai,
R. M. Be,
and
D. N. Granger.
Effects of neutrophil-derived oxidants on intestinal permeability, electrolyte transport and epithelial cell viability.
Inflammation
14:
531-542,
1990[Medline].
27.
Gutteridge, J. M. C.
The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation.
Biochim. Biophys. Acta
917:
219-223,
1987[Medline].
28.
Hai, T. T.,
D. Nelson,
D. Pereira,
and
A. Srnak.
Diaspirin crosslinked hemoglobin (DCLHb) polymerization.
Artif. Cells Blood Substit. Immobil. Biotechnol.
22:
923-931,
1994[Medline].
29.
Harrison, G. J.,
L. R. Jordan,
and
R. J. Willis.
Deleterious effects of hydrogen peroxide on the function and ultrastructure of cardiac muscle and the coronary vasculature of perfused rat hearts.
Can. J. Cardiol.
10:
843-849,
1994[Medline].
30.
Hess, R. J.,
and
R. F. Reiss.
Resuscitation and limited utility of the present generation of blood substitutes.
Transfus. Med. Rev.
10:
276-285,
1996[Medline].
31.
Kawamura, K.,
S. Kagiyama,
A. Ogawa,
and
T. Yanase.
Kinetics of peroxidase activity, absorption spectra and oxygen affinity of human-haptoglobin I-I complexes.
Biochim. Biophys. Acta
285:
22-27,
1972[Medline].
32.
Krishna, M. C.,
A. Samuni,
J. Taira,
S. Goldstein,
J. B. Mitchell,
and
A. Russo.
Stimulation by nitroxides of catalase-like activity of hemeproteins: kinetics and mechanism.
J. Biol. Chem.
271:
26015-26025,
1996.
33.
Kvietys, P. R.,
W. Inauen,
B. R. Bacon,
and
M. B. Grisham.
Xanthine oxidase-induced injury to endothelium: role of intracellular iron and hydroxyl radical.
Am. J. Physiol.
257 (Heart Circ. Physiol. 26):
H1640-H1646,
1989
34.
Lee, R.,
K. Neya,
T. A. Svizzero,
and
G. J. Vlahakas.
Limitations of the efficacy of hemoglobin-based oxygen carrying solutions.
J. Appl. Physiol.
79:
236-242,
1995
35.
Marks, D. H.,
T. Cooper,
T. Makovec,
C. Okeberg,
and
L. O. Lollini.
Effect of polymyxin B on hemoglobin-mediated hepatotoxicity.
Mil. Med.
154:
180-184,
1989[Medline].
36.
Matzinger, P.
The JAM test: a simple assay for DNA fragmentation and cell death.
J. Immunol. Methods
145:
185-192,
1991[Medline].
37.
Misra, H. P.,
and
I. Fridovich.
The generation of superoxide radical during the autoxidation of hemoglobin.
J. Biol. Chem.
247:
6960-6962,
1972
38.
Motterlini, R.
Interaction of hemoglobin with nitric oxide and carbon monoxide: physiological implications.
In: Blood Substitutes: New Challenges, edited by R. M. Winslow,
K. D. Vandegriff,
and M. Intaglietta. Boston, MA: Birkhäuser, 1996, p. 74-98.
39.
Motterlini, R.,
R. Foresti,
K. Vandegriff,
M. Intaglietta,
and
R. M. Winslow.
Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions.
Am. J. Physiol.
269 (Heart Circ. Physiol. 38):
H648-H655,
1995
40.
Motterlini, R.,
and
V. W. MacDonald.
Cell-free hemoglobin potentiates acetylcholine-induced coronary vasoconstriction in rabbit hearts.
J. Appl. Physiol.
75:
2224-2233,
1993
41.
Natarajan, V.
Oxidants and signal transduction in vascular endothelium.
J. Lab. Clin. Med.
125:
26-37,
1995[Medline].
42.
Nath, K. A.
The functional significance of induction of heme oxygenase by oxidant stress.
J. Lab. Clin. Med.
123:
461-463,
1994[Medline].
43.
Nath, K. A.,
J. Balla,
A. J. Croatt,
and
G. M. Vercellotti.
Heme protein-mediated renal injury: a protective role for 21-aminosteroids in vitro and in vivo.
Kidney Int.
47:
592-602,
1995[Medline].
44.
Palmer, R. M. J.,
A. G. Ferrige,
and
S. Moncada.
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
Nature
327:
524-526,
1989.
45.
Panter, S. S.,
K. D. Vandegriff,
P. O. Yan,
and
R. F. Regan.
Assessment of hemoglobin-dependent neurotoxicity: alpha-alpha crosslinked hemoglobin.
Artif. Cells Blood Substit. Immobil. Biotechnol.
22:
399-413,
1994[Medline].
47.
Rogers, M. S.,
B. Brockner-Ryan,
R. E. Cashon,
and
A. I. Alayash.
Effects of polymerization on the oxygen carrying and redox properties of diaspirin cross-linked hemoglobin.
Biochim. Biophys. Acta
1248:
135-142,
1991.
48.
Rogers, M. S.,
M. P. Patel,
B. J. Reeder,
P. Sarti,
M. T. Wilson,
and
A. I. Alayash.
Pro-oxidant effects of cross-linked haemoglobins explored using liposome and cytochrome c oxidase vesicle model membranes.
Biochem. J.
310:
827-833,
1995.
49.
Sanders, K. E.,
G. Ackers,
and
S. Sligar.
Engineering and design of blood substitutes.
Curr. Opin. Struct. Biol.
6:
534-540,
1996[Medline].
50.
Savitsky, J. P.,
J. Doczi,
J. Black,
and
J. D. Arnold.
A clinical safety trial of stroma-free hemoglobin.
Clin. Pharmacol. Ther.
23:
73-78,
1978[Medline].
51.
Sharma, V.,
T. Traylor,
and
R. Gardiner.
Reaction of nitric oxide with heme proteins and model compounds of hemoglobin.
Biochemistry
26:
3837-3843,
1987[Medline].
52.
Simoni, J.,
G. Simoni,
C. D. Lox,
and
M. Feola.
Reaction of human endothelial cells to bovine hemoglobin solutions and tumor necrosis factor.
Artif. Cells Blood Substit. Immobil. Biotechnol.
22:
777-787,
1994[Medline].
53.
Snyder, S. R.,
E. V. Welty,
R. Y. Walder,
L. A. Williams,
and
J. A. Walder.
HbXL99a: a hemoglobin derivative that is cross-linked between
subunits is useful as a blood substitute.
Proc. Natl. Acad. Sci. USA
84:
7280-7284,
1987
54.
Svistunenko, D. A.,
R. P. Patel,
S. V. Voloshchenko,
and
M. T. Wilson.
The globin-based free radical of ferryl hemoglobin is detected in normal human blood.
J. Biol. Chem.
272:
7114-7121,
1997
55.
Voyta, J. C.,
D. P. Via,
C. E. Butterfield,
and
B. R. Zetter.
Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein.
J. Cell Biol.
99:
2034-2040,
1984
56.
Winterborn, C. C.
Reactions of superoxide with hemoglobin.
In: CRC Handbook of Methods for Oxygen Radical Research, edited by R. A. Greenwald. Boca Raton: CRC, 1985, p. 137-141.
This article has been cited by other articles:
![]() |
F. D'Agnillo and A. I. Alayash Redox cycling of diaspirin cross-linked hemoglobin induces G2/M arrest and apoptosis in cultured endothelial cells Blood, December 1, 2001; 98(12): 3315 - 3323. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D'Agnillo and A. I. Alayash Interactions of hemoglobin with hydrogen peroxide alters thiol levels and course of endothelial cell death Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1880 - H1889. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deem, J. T. Berg, M. E. Kerr, and E. R. Swenson Effects of the RBC membrane and increased perfusate viscosity on hypoxic pulmonary vasoconstriction J Appl Physiol, May 1, 2000; 88(5): 1520 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. McLeod and A. I. Alayash Detection of a ferrylhemoglobin intermediate in an endothelial cell model after hypoxia-reoxygenation Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H92 - H99. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Alayash, B. A. B. Ryan, R. F. Eich, J. S. Olson, and R. E. Cashon Reactions of Sperm Whale Myoglobin with Hydrogen Peroxide. EFFECTS OF DISTAL POCKET MUTATIONS ON THE FORMATION AND STABILITY OF THE FERRYL INTERMEDIATE J. Biol. Chem., January 22, 1999; 274(4): 2029 - 2037. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |